- Home
- OFIX vs SVRA Comparison
OFIX vs SVRA Comparison
Compare OFIX & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFIX
- SVRA
- Stock Information
- Founded
- OFIX 1987
- SVRA 2007
- Country
- OFIX United States
- SVRA United States
- Employees
- OFIX N/A
- SVRA N/A
- Industry
- OFIX Medical/Dental Instruments
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- OFIX Health Care
- SVRA Health Care
- Exchange
- OFIX Nasdaq
- SVRA Nasdaq
- Market Cap
- OFIX 564.4M
- SVRA 527.2M
- IPO Year
- OFIX N/A
- SVRA N/A
- Fundamental
- Price
- OFIX $16.16
- SVRA $5.32
- Analyst Decision
- OFIX Strong Buy
- SVRA Buy
- Analyst Count
- OFIX 5
- SVRA 8
- Target Price
- OFIX $21.50
- SVRA $6.88
- AVG Volume (30 Days)
- OFIX 267.9K
- SVRA 1.9M
- Earning Date
- OFIX 11-04-2025
- SVRA 11-12-2025
- Dividend Yield
- OFIX N/A
- SVRA N/A
- EPS Growth
- OFIX N/A
- SVRA N/A
- EPS
- OFIX N/A
- SVRA N/A
- Revenue
- OFIX $818,058,000.00
- SVRA N/A
- Revenue This Year
- OFIX $3.79
- SVRA N/A
- Revenue Next Year
- OFIX $5.66
- SVRA N/A
- P/E Ratio
- OFIX N/A
- SVRA N/A
- Revenue Growth
- OFIX 4.31
- SVRA N/A
- 52 Week Low
- OFIX $10.24
- SVRA $1.89
- 52 Week High
- OFIX $20.48
- SVRA $5.33
- Technical
- Relative Strength Index (RSI)
- OFIX 62.19
- SVRA 76.86
- Support Level
- OFIX $14.26
- SVRA $4.59
- Resistance Level
- OFIX $16.34
- SVRA $4.38
- Average True Range (ATR)
- OFIX 0.67
- SVRA 0.28
- MACD
- OFIX 0.12
- SVRA 0.10
- Stochastic Oscillator
- OFIX 89.57
- SVRA 100.00
About OFIX Orthofix Medical Inc. (DE)
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.